Life sciences news
-
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications
Friday May 31st 2024
Read more
-
reMYND announces publication in Science of novel drug target with potential for development into transformative treatments for Alzheimer’s disease
Thursday May 30th 2024
Read more
-
Waste2Func Video Release: The technology is ready, are we?
Friday May 24th 2024
Read more
-
BIO INX and Readily3D Announce Collaboration to Advance Volumetric Bioprinting with Cutting-edge Gel-MA Based Ink
Wednesday May 22nd 2024
Read more
-
Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®
Wednesday May 22nd 2024
Read more
-
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.
Friday May 17th 2024
Read more
-
20 years of progress: flanders.bio and VIB put biotech and life sciences in spotlight
Wednesday May 15th 2024
Read more
-
Mithra announces grant of two additional U.S. patents for NEXTSTELLIS®
Monday May 13th 2024
Read more
-
Become a flanders.bio member
Your news here?
-
Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMD
Tuesday May 7th 2024
Read more
-
KU Leuven Secures $2.8 Million Grant to Investigate Origins of Crohn’s Disease Fibrosis
Friday May 3rd 2024
Read more
-
Biotalys starts field trials for second biofungicide
Thursday May 2nd 2024
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
